简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2024-01-24 14:14 BeiGene Welcomes Experienced Life Sciences Executive Olivier Brandicourt to Board of Directors
2024-01-23 10:17 Multiple New Analyses Reinforce the Role of BAVENCIO® (avelumab) First-Line Maintenance as a Standard of Care in Patients with Locally Advanced or Metastatic Urothelial Carcinoma
2024-01-22 15:21 Galderma Announces Regulatory Approval for Restylane® SHAYPE™, a New Hyaluronic Acid Injectable Designed for Augmenting the Chin Region
2024-01-19 19:31 Fujirebio and Agappe Enter into an Agreement on Business Collaboration in the Field of CLIA Based Immunoassay
2024-01-19 13:49 Hyperice Expands IP Enforcement Action, Files Percussion Patent Infringement Lawsuits Against Sharper Image, HoMedics, Ekrin Athletics, and Over a Dozen Others
2024-01-19 13:22 Sinovac Board of Directors Unanimously Rejects an Unsolicited Partial Tender Offer
2024-01-19 10:37 ELIQUENT Life Sciences Announces Acquisition of European-Focused Regulatory Partner: RApport Global Strategic Services
2024-01-19 10:33 Takeda Named Global Top Employer for Seventh Consecutive Year
2024-01-18 12:42 Timeline, a Swiss Longevity Biotech, Secures Pivotal Financing Round with Support from Strategic Global Industry Leaders, including L’Oréal and Nestlé
2024-01-17 14:24 TOXINS 2024: Galderma’s Phase III RelabotulinumtoxinA Results Demonstrate Positive Efficacy and Long Duration of Effect When Treating Frown Lines and Crow’s Feet Simultaneously
2024-01-17 11:26 Parse Biosciences Acquires Biomage
2024-01-17 11:22 Xenco Medical Unveils the TrabeculeX Continuum, a Breakthrough Convergence of Digital Health and Biomaterials, at CES 2024 in Las Vegas, the World’s Largest Technology Conference
2024-01-17 10:56 KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions
2024-01-17 09:03 Women's Health Remains in Crisis Worldwide Even as COVID-19 Pandemic Wanes
2024-01-17 09:01 U.S. FDA Approves Takeda’s HYQVIA® as Maintenance Therapy in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
2024-01-16 10:35 Neuraptive Therapeutics Inc. Receives Orphan Drug Designation for its Lead Development Asset
2024-01-12 12:29 ELIQUENT Life Sciences Announces Steve Purtell as Chief Financial Officer
2024-01-11 10:13 QPS Significantly Enhances Mass Spectrometry Laboratory Capacity
2024-01-11 09:10 Medidata Secures Top Honors in Everest Group's Decentralized Clinical Trial Platforms PEAK Matrix® Assessment
2024-01-11 09:03 Myrobalan Therapeutics Completes Series A Financing of $24 Million to Develop Potentially First-in-Class CNS Therapeutics with Restorative Potential

Business Wire Weibo

Press Releases

Latest Releases